Time Trends in Patient Characteristics of New Rivaroxaban Users with Atrial Fibrillation in Germany and the Netherlands-Reference-Cited by-同舟云学术

Time Trends in Patient Characteristics of New Rivaroxaban Users with Atrial Fibrillation in Germany and the Netherlands

Published:2023-02-01 Issue:2 Volume:10 Page:215-224
ISSN:2199-1154
Container-title:Drugs - Real World Outcomes
language:en
Short-container-title:Drugs - Real World Outcomes

Author:

Voss Annemarie^ORCID,Smits Elisabeth^ORCID,Swart Karin M. A.^ORCID,Balabanova Yanina^ORCID,Brobert Gunnar^ORCID,Suzart-Woischnik Kiliana^ORCID,Herings Ron M. C.^ORCID,Schink Tania^ORCID,Haug Ulrike^ORCID

Funder

Pharmaceuticals Bayer

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Link

https://link.springer.com/content/pdf/10.1007/s40801-022-00350-2.pdf

Reference26 articles.

1. Ruff CT, Giugliano RP, Braunwald E, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet. 2014;383(9921):955–62. https://doi.org/10.1016/S0140-6736(13)62343-0.

2. Friberg L, Oldgren J. Efficacy and safety of non-vitamin K antagonist oral anticoagulants compared with warfarin in patients with atrial fibrillation. Open Heart. 2017. https://doi.org/10.1136/openhrt-2017-000682.

3. Esteve-Pastor MA, Rivera-Caravaca JM, Roldan V, et al. Estimated effectiveness and safety of nonvitamin K antagonist oral anticoagulants compared with optimally acenocoumarol anticoagulated “real-world” in patients with atrial fibrillation. JACC. 2018;122(5):785–92. https://doi.org/10.1016/j.amjcard.2018.05.012.

4. Rodríguez-Bernal CL, Santa-Ana-Téllez Y, García-Sempere A, et al. Clinical outcomes of nonvitamin K oral anticoagulants and acenocoumarol for stroke prevention in contemporary practice: a population-based propensity-weighted cohort study. Br J Clin Pharmacol. 2021;87(2):632–43. https://doi.org/10.1111/bcp.14430.

5. Hohnloser SH, Basic E, Hohmann C, et al. Effectiveness and safety of non–vitamin K oral anticoagulants in comparison to phenprocoumon: data from 61,000 patients with atrial fibrillation. Thromb Haemost. 2018;118(03):526–38. https://doi.org/10.1160/TH17-10-0733.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk Profiles of New Users of Oral Anticoagulants Between 2011 and 2019 in Germany;Clinical Epidemiology;2023-07